Related Experiment Videos

Assessment of Susceptibility of Methicillin-Resistant Staphylococcus aureus Isolates to Ceftaroline and Other

Rishabh Gupta1, Saumya Agarwal1, Haniya Jafar1

  • 1Department of Microbiology, Rohilkhand Medical College and Hospital, Bareilly, IND.

Cureus
|August 16, 2026
PubMed

Insights

Ceftaroline shows high in vitro activity against methicillin-resistant Staphylococcus aureus (MRSA) isolates. Susceptibility remained consistent across patient demographics and specimen types, supporting its use for MRSA infections.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Clinical Pharmacy

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) is a significant cause of healthcare-associated infections.
  • Limited treatment options exist due to widespread antimicrobial resistance.
  • Understanding ceftaroline's efficacy against MRSA is crucial for treatment strategies.

Purpose of the Study:

  • To evaluate the in vitro susceptibility of clinical MRSA isolates to ceftaroline.
  • To determine ceftaroline susceptibility patterns across demographic and clinical variables.
  • To compare ceftaroline activity with other antibiotics.

Main Methods:

  • Cross-sectional observational study of 250 clinical MRSA isolates.
  • Antimicrobial susceptibility testing following CLSI guidelines.
  • Statistical analysis of demographic, clinical, and microbiological data.

Main Results:

  • 84.8% of MRSA isolates were susceptible to ceftaroline; 14.4% showed intermediate susceptibility.
  • Ceftaroline susceptibility was consistent across sex, age, hospital department, and specimen type.
  • Vancomycin and linezolid showed high susceptibility (100% and 98.8%, respectively).

Conclusions:

  • Ceftaroline exhibits substantial in vitro activity against clinical MRSA isolates.
  • Its effectiveness is consistent across various patient and clinical subgroups.
  • Findings support ceftaroline as a potential therapeutic option for MRSA infections, emphasizing surveillance.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...